J1445 — Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron
J1445 is a HCPCS Level II code for injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J1445 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J1445
- Long descriptor
- Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron
- Short descriptor
- Inj triferic avnu 0.1mg iron
- Added
- October 1, 2021
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J1445
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1445 is not quite right, the correct code is very often within a few positions of it.
- J1436Injection, etidronate disodium, per 300 mg
- J1437Injection, ferric derisomaltose, 10 mg
- J1438Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J1439Injection, ferric carboxymaltose, 1 mg
- J1440Fecal microbiota, live - jslm, 1 ml
- J1442Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
- J1443Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of ironterminated
- J1444Injection, ferric pyrophosphate citrate powder, 0.1 mg of ironterminated
- J1446Injection, tbo-filgrastim, 5 microgramsterminated
- J1447Injection, tbo-filgrastim, 1 microgram
- J1448Injection, trilaciclib, 1mg
- J1449Injection, eflapegrastim-xnst, 0.1 mg
- J1450Injection fluconazole, 200 mg
- J1451Injection, fomepizole, 15 mg
- J1452Injection, fomivirsen sodium, intraocular, 1.65 mgterminated
- J1453Injection, fosaprepitant, 1 mg
Questions about J1445
What is HCPCS code J1445?
J1445 is a HCPCS Level II code for injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J1445?
The CMS HCPCS file marks J1445 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J1445 still valid?
No. J1445 was terminated on December 31, 2025 and should not be used on new claims.